drugset
drugset / Trial / NCT00663455

Randomized Study to Reduce Calcineurininhibitor Toxicity in Pediatric and Adolescent Kidney Transplant Recipients

NCT00663455 ↗

Phase 4 Terminated 50 enrolled University of Erlangen-Nürnberg Medical School
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine if a safe reduction of cyclosporine A in pediatric and adolescent patients with stable renal graft function, reduces signs of calcineurin-inhibitor toxicity.

Timeline

Start
2008-12
Primary completion
2012-12
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclosporine Peptide — —

Indications

No indication recorded.